#psychedelictherapy

Psychedelic InstitutePsychedelicInstitute
2025-09-24

psychedelicmentalhealth.net/co Comparative Effects of Repeated Ketamine Infusion Versus Intranasal Esketamine in Patients With Treatment-Resistant Depression: A Retrospective Chart Review (Meisner, et al, 2025) "treatment with IV racemic ketamine was associated with a more rapid response and greater overall efficacy than treatment with IN esketamine."

Michalina OGo_porridge
2025-09-22

Podpisałam europejską petycję w sprawie terapii wspomaganych psychodelikami i was również do tego zachęcam.

Psylocybina i MDMA wykazują skuteczność w leczeniu depresji lekoopornej, PTSD. UE finansuje projekty badawcze, ale brak jednolitych regulacji utrudnia rozwój leczenia i chronionego dostępu.

To, że ta rewolucja się dzieje jest ewidentne lecz jej kierunek i tempo jest również zależne od zaangażowania obywateli.

eci.ec.europa.eu/050/public/

Psychedelic InstitutePsychedelicInstitute
2025-09-19

psychedelicmentalhealth.net/ps Psychedelics and mental health: reimagining care through science, insight, and compassion (Mikellides, et al, 2025) "These substances are not stand-alone medications; rather, they function as adjuncts to intensive psychotherapeutic processes. Training therapists and establishing ethical, evidence-based protocols is essential."

Psychedelic InstitutePsychedelicInstitute
2025-09-14

psychedelicmentalhealth.net/de Spotlight: Psilocybin with psychotherapy trial shows participants in remission for depression 5 years later. "when it comes to reducing depression with psychedelic-assisted therapy, what matters even more than the drug is a strong relationship between the therapist and study participant." "

Wild Sownwildsown
2025-09-07

"A rigorous new study finds that a single dose of LSD can ease anxiety and depression for months.

The study involved 198 adults with generalized anxiety disorder, ...

... people who received higher doses (100 or 200 micrograms) responded quickly, a team reports in the Journal of the American Medical Association."

npr.org/sections/shots-health-

Psychedelic InstitutePsychedelicInstitute
2025-09-05

akjournals.com/view/journals/2 Exploring barriers and opportunities for Black, Indigenous, and People of Color (BIPOC) therapists in psychedelic-assisted therapy: A qualitative study

Psychedelic InstitutePsychedelicInstitute
2025-09-04

pubmed.ncbi.nlm.nih.gov/409011 Optimizing ketamine dosing strategies across diverse clinical applications: a comprehensive review (Kedwany, et al, 2025)

Psychedelic InstitutePsychedelicInstitute
2025-09-03

psychedelicmentalhealth.net/sp Spotlight: Psychedelics and mental health: reimagining care through science, insight, and compassion (Mikellides, et al, 2025) "These substances...function as adjuncts to intensive psychotherapeutic processes. Training therapists and establishing ethical, evidence-based protocols is essential...Ketamine’s entry into psychiatric practice has paved the way for psychedelics."

Psychedelic InstitutePsychedelicInstitute
2025-08-26

Spotlight: Positive Phase 2 Results: Psilocybin-Assisted Psychotherapy Treatment, PSX-001, for Generalized Anxiety Disorder (2025) All participants received equal hours of psychological support and preparation, ensuring that any treatment effect could be attributed to psilocybin itself and not therapeutic bias. psychedelicmentalhealth.net/sp

Psychedelic InstitutePsychedelicInstitute
2025-08-22

psychedelicmentalhealth.net/sp Deconstructing the trip treatment: are hallucinogenic effects critical to the therapeutic benefits of psychedelics? (Garcia-Romeu, 2025)

The relative contribution of drug vs. psychological support remains to be determined, though preliminary data indicate the therapeutic relationship can impact treatment outcomes [12], and factors such as environment, personality, and mindset can influence subjective drug effects.

Psychedelic InstitutePsychedelicInstitute
2025-08-22

psychedelicmentalhealth.net/sp Spotlight: Endocannabinoids, depression, and treatment resistance: Perspectives on effective therapeutic interventions (Rosa, et al, 2025) "glutamatergic and serotonergic agents such as ketamine, esketamine, and psychedelics, influence ECS components."

Psychedelic InstitutePsychedelicInstitute
2025-08-13

Psychedelic Cognitive Behavioral Therapy: On Ketamine, Context and Competencies in "Assisted-Psychotherapy”

There are many tools to help a psychotherapist help clients learn to speak the language of cognitive behavioral therapy, especially tools which may help facilitate therapeutic alliance, including, but not limited to telehealth. psychedelicmentalhealth.net/ps

Client Info

Server: https://mastodon.social
Version: 2025.07
Repository: https://github.com/cyevgeniy/lmst